Sirtuin 4 (SIRT4), a member of the sirtuin proteins family, has been implicated in the regulation of cancer cell toxicity through the modulation of glutamate dehydrogenase [15] and enhancing the sensitivity of ER + BC cells to tamoxifen [16]. This evidence concerns the gene SIRT4 and breast cancer.